Exact Sciences Corp.’s recently made public that its President and CEO Conroy Kevin T unloaded Company’s shares for reported $69473.0 on May 01 ’24. In the deal valued at $60.15 per share,1,155 shares were sold. As a result of this transaction, Conroy Kevin T now holds 1,156,191 shares worth roughly $64.48 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Cunningham Everett sold 136 shares, generating $8,180 in total proceeds. Upon selling the shares at $60.15, the Chief Commercial Officer now owns 47,042 shares.
Before that, Elliott Jeffrey Thomas sold 136 shares. Exact Sciences Corp. shares valued at $8,180 were divested by the Chief Financial Officer at a price of $60.15 per share. As a result of the transaction, Elliott Jeffrey Thomas now holds 11,795 shares, worth roughly $0.66 million.
Scotiabank initiated its Exact Sciences Corp. [EXAS] rating to a Sector outperform in a research note published on June 27, 2024; the price target was $70. The Benchmark Company also remained covering EXAS and has increased its forecast on January 02, 2024 with a “Buy” recommendation from previously “Hold” rating. Guggenheim started covering the stock on December 14, 2023. It rated EXAS as “a Buy”.
Price Performance Review of EXAS
On Monday, Exact Sciences Corp. [NASDAQ:EXAS] saw its stock fall -2.76% to $55.77. Over the last five days, the stock has gained 22.41%. Exact Sciences Corp. shares have fallen nearly -24.61% since the year began. Nevertheless, the stocks have fallen -36.50% over the past one year. While a 52-week high of $88.62 was reached on 04/02/24, a 52-week low of $40.62 was recorded on 06/25/24. SMA at 50 days reached $45.87, while 200 days put it at $59.27. A total of 3.3 million shares were traded, compared to the trading of 5.21 million shares in the previous session.
Levels Of Support And Resistance For EXAS Stock
The 24-hour chart illustrates a support level at 54.09, which if violated will result in even more drops to 52.42. On the upside, there is a resistance level at 57.39. A further resistance level may holdings at 59.02. The Relative Strength Index (RSI) on the 14-day chart is 65.13, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.61, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 16.61%. Stochastics%K at 91.94% indicates the stock is a selling.
The most recent change occurred on December 13, 2023 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $95 price target.
